img

Global OTC Drug and Dietary Supplement Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global OTC Drug and Dietary Supplement Market Research Report 2024

Dietary supplements include such ingredients as vitamins, minerals, herbs, amino acids, and enzymes. Dietary supplements are marketed in forms such as tablets, capsules, softgels, gelcaps, powders, and liquids.
According to Mr Accuracy reports’s new survey, global OTC Drug and Dietary Supplement market is projected to reach US$ million in 2034, increasing from US$ million in 2024, with the CAGR of % during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole OTC Drug and Dietary Supplement market research.
Key companies engaged in the OTC Drug and Dietary Supplement industry include Pfizer, Amway, Suntory, Glanbia, GSK, Abbott, Herbalife, Reckitt Benckiser and Bayer, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % value of OTC Drug and Dietary Supplement were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole OTC Drug and Dietary Supplement market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global OTC Drug and Dietary Supplement market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Pfizer
Amway
Suntory
Glanbia
GSK
Abbott
Herbalife
Reckitt Benckiser
Bayer
Blackmores
Segment by Type
Tablets
Powders
Capsules
Liquids

Segment by Application


Convenience Stores
Pharmacies
Supermarkets
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The OTC Drug and Dietary Supplement report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global OTC Drug and Dietary Supplement Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 Tablets
1.2.3 Powders
1.2.4 Capsules
1.2.5 Liquids
1.3 Market by Application
1.3.1 Global OTC Drug and Dietary Supplement Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Convenience Stores
1.3.3 Pharmacies
1.3.4 Supermarkets
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global OTC Drug and Dietary Supplement Market Perspective (2018-2034)
2.2 OTC Drug and Dietary Supplement Growth Trends by Region
2.2.1 Global OTC Drug and Dietary Supplement Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 OTC Drug and Dietary Supplement Historic Market Size by Region (2018-2023)
2.2.3 OTC Drug and Dietary Supplement Forecasted Market Size by Region (2024-2034)
2.3 OTC Drug and Dietary Supplement Market Dynamics
2.3.1 OTC Drug and Dietary Supplement Industry Trends
2.3.2 OTC Drug and Dietary Supplement Market Drivers
2.3.3 OTC Drug and Dietary Supplement Market Challenges
2.3.4 OTC Drug and Dietary Supplement Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top OTC Drug and Dietary Supplement Players by Revenue
3.1.1 Global Top OTC Drug and Dietary Supplement Players by Revenue (2018-2023)
3.1.2 Global OTC Drug and Dietary Supplement Revenue Market Share by Players (2018-2023)
3.2 Global OTC Drug and Dietary Supplement Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by OTC Drug and Dietary Supplement Revenue
3.4 Global OTC Drug and Dietary Supplement Market Concentration Ratio
3.4.1 Global OTC Drug and Dietary Supplement Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by OTC Drug and Dietary Supplement Revenue in 2024
3.5 OTC Drug and Dietary Supplement Key Players Head office and Area Served
3.6 Key Players OTC Drug and Dietary Supplement Product Solution and Service
3.7 Date of Enter into OTC Drug and Dietary Supplement Market
3.8 Mergers & Acquisitions, Expansion Plans
4 OTC Drug and Dietary Supplement Breakdown Data by Type
4.1 Global OTC Drug and Dietary Supplement Historic Market Size by Type (2018-2023)
4.2 Global OTC Drug and Dietary Supplement Forecasted Market Size by Type (2024-2034)
5 OTC Drug and Dietary Supplement Breakdown Data by Application
5.1 Global OTC Drug and Dietary Supplement Historic Market Size by Application (2018-2023)
5.2 Global OTC Drug and Dietary Supplement Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America OTC Drug and Dietary Supplement Market Size (2018-2034)
6.2 North America OTC Drug and Dietary Supplement Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America OTC Drug and Dietary Supplement Market Size by Country (2018-2023)
6.4 North America OTC Drug and Dietary Supplement Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe OTC Drug and Dietary Supplement Market Size (2018-2034)
7.2 Europe OTC Drug and Dietary Supplement Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe OTC Drug and Dietary Supplement Market Size by Country (2018-2023)
7.4 Europe OTC Drug and Dietary Supplement Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific OTC Drug and Dietary Supplement Market Size (2018-2034)
8.2 Asia-Pacific OTC Drug and Dietary Supplement Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific OTC Drug and Dietary Supplement Market Size by Region (2018-2023)
8.4 Asia-Pacific OTC Drug and Dietary Supplement Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America OTC Drug and Dietary Supplement Market Size (2018-2034)
9.2 Latin America OTC Drug and Dietary Supplement Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America OTC Drug and Dietary Supplement Market Size by Country (2018-2023)
9.4 Latin America OTC Drug and Dietary Supplement Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa OTC Drug and Dietary Supplement Market Size (2018-2034)
10.2 Middle East & Africa OTC Drug and Dietary Supplement Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa OTC Drug and Dietary Supplement Market Size by Country (2018-2023)
10.4 Middle East & Africa OTC Drug and Dietary Supplement Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer OTC Drug and Dietary Supplement Introduction
11.1.4 Pfizer Revenue in OTC Drug and Dietary Supplement Business (2018-2023)
11.1.5 Pfizer Recent Development
11.2 Amway
11.2.1 Amway Company Detail
11.2.2 Amway Business Overview
11.2.3 Amway OTC Drug and Dietary Supplement Introduction
11.2.4 Amway Revenue in OTC Drug and Dietary Supplement Business (2018-2023)
11.2.5 Amway Recent Development
11.3 Suntory
11.3.1 Suntory Company Detail
11.3.2 Suntory Business Overview
11.3.3 Suntory OTC Drug and Dietary Supplement Introduction
11.3.4 Suntory Revenue in OTC Drug and Dietary Supplement Business (2018-2023)
11.3.5 Suntory Recent Development
11.4 Glanbia
11.4.1 Glanbia Company Detail
11.4.2 Glanbia Business Overview
11.4.3 Glanbia OTC Drug and Dietary Supplement Introduction
11.4.4 Glanbia Revenue in OTC Drug and Dietary Supplement Business (2018-2023)
11.4.5 Glanbia Recent Development
11.5 GSK
11.5.1 GSK Company Detail
11.5.2 GSK Business Overview
11.5.3 GSK OTC Drug and Dietary Supplement Introduction
11.5.4 GSK Revenue in OTC Drug and Dietary Supplement Business (2018-2023)
11.5.5 GSK Recent Development
11.6 Abbott
11.6.1 Abbott Company Detail
11.6.2 Abbott Business Overview
11.6.3 Abbott OTC Drug and Dietary Supplement Introduction
11.6.4 Abbott Revenue in OTC Drug and Dietary Supplement Business (2018-2023)
11.6.5 Abbott Recent Development
11.7 Herbalife
11.7.1 Herbalife Company Detail
11.7.2 Herbalife Business Overview
11.7.3 Herbalife OTC Drug and Dietary Supplement Introduction
11.7.4 Herbalife Revenue in OTC Drug and Dietary Supplement Business (2018-2023)
11.7.5 Herbalife Recent Development
11.8 Reckitt Benckiser
11.8.1 Reckitt Benckiser Company Detail
11.8.2 Reckitt Benckiser Business Overview
11.8.3 Reckitt Benckiser OTC Drug and Dietary Supplement Introduction
11.8.4 Reckitt Benckiser Revenue in OTC Drug and Dietary Supplement Business (2018-2023)
11.8.5 Reckitt Benckiser Recent Development
11.9 Bayer
11.9.1 Bayer Company Detail
11.9.2 Bayer Business Overview
11.9.3 Bayer OTC Drug and Dietary Supplement Introduction
11.9.4 Bayer Revenue in OTC Drug and Dietary Supplement Business (2018-2023)
11.9.5 Bayer Recent Development
11.10 Blackmores
11.10.1 Blackmores Company Detail
11.10.2 Blackmores Business Overview
11.10.3 Blackmores OTC Drug and Dietary Supplement Introduction
11.10.4 Blackmores Revenue in OTC Drug and Dietary Supplement Business (2018-2023)
11.10.5 Blackmores Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global OTC Drug and Dietary Supplement Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of Tablets
Table 3. Key Players of Powders
Table 4. Key Players of Capsules
Table 5. Key Players of Liquids
Table 6. Global OTC Drug and Dietary Supplement Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 7. Global OTC Drug and Dietary Supplement Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 8. Global OTC Drug and Dietary Supplement Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global OTC Drug and Dietary Supplement Market Share by Region (2018-2023)
Table 10. Global OTC Drug and Dietary Supplement Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 11. Global OTC Drug and Dietary Supplement Market Share by Region (2024-2034)
Table 12. OTC Drug and Dietary Supplement Market Trends
Table 13. OTC Drug and Dietary Supplement Market Drivers
Table 14. OTC Drug and Dietary Supplement Market Challenges
Table 15. OTC Drug and Dietary Supplement Market Restraints
Table 16. Global OTC Drug and Dietary Supplement Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global OTC Drug and Dietary Supplement Market Share by Players (2018-2023)
Table 18. Global Top OTC Drug and Dietary Supplement Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Drug and Dietary Supplement as of 2024)
Table 19. Ranking of Global Top OTC Drug and Dietary Supplement Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by OTC Drug and Dietary Supplement Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players OTC Drug and Dietary Supplement Product Solution and Service
Table 23. Date of Enter into OTC Drug and Dietary Supplement Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global OTC Drug and Dietary Supplement Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global OTC Drug and Dietary Supplement Revenue Market Share by Type (2018-2023)
Table 27. Global OTC Drug and Dietary Supplement Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 28. Global OTC Drug and Dietary Supplement Revenue Market Share by Type (2024-2034)
Table 29. Global OTC Drug and Dietary Supplement Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global OTC Drug and Dietary Supplement Revenue Market Share by Application (2018-2023)
Table 31. Global OTC Drug and Dietary Supplement Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 32. Global OTC Drug and Dietary Supplement Revenue Market Share by Application (2024-2034)
Table 33. North America OTC Drug and Dietary Supplement Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 34. North America OTC Drug and Dietary Supplement Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America OTC Drug and Dietary Supplement Market Size by Country (2024-2034) & (US$ Million)
Table 36. Europe OTC Drug and Dietary Supplement Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 37. Europe OTC Drug and Dietary Supplement Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe OTC Drug and Dietary Supplement Market Size by Country (2024-2034) & (US$ Million)
Table 39. Asia-Pacific OTC Drug and Dietary Supplement Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 40. Asia-Pacific OTC Drug and Dietary Supplement Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific OTC Drug and Dietary Supplement Market Size by Region (2024-2034) & (US$ Million)
Table 42. Latin America OTC Drug and Dietary Supplement Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 43. Latin America OTC Drug and Dietary Supplement Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America OTC Drug and Dietary Supplement Market Size by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa OTC Drug and Dietary Supplement Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 46. Middle East & Africa OTC Drug and Dietary Supplement Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa OTC Drug and Dietary Supplement Market Size by Country (2024-2034) & (US$ Million)
Table 48. Pfizer Company Detail
Table 49. Pfizer Business Overview
Table 50. Pfizer OTC Drug and Dietary Supplement Product
Table 51. Pfizer Revenue in OTC Drug and Dietary Supplement Business (2018-2023) & (US$ Million)
Table 52. Pfizer Recent Development
Table 53. Amway Company Detail
Table 54. Amway Business Overview
Table 55. Amway OTC Drug and Dietary Supplement Product
Table 56. Amway Revenue in OTC Drug and Dietary Supplement Business (2018-2023) & (US$ Million)
Table 57. Amway Recent Development
Table 58. Suntory Company Detail
Table 59. Suntory Business Overview
Table 60. Suntory OTC Drug and Dietary Supplement Product
Table 61. Suntory Revenue in OTC Drug and Dietary Supplement Business (2018-2023) & (US$ Million)
Table 62. Suntory Recent Development
Table 63. Glanbia Company Detail
Table 64. Glanbia Business Overview
Table 65. Glanbia OTC Drug and Dietary Supplement Product
Table 66. Glanbia Revenue in OTC Drug and Dietary Supplement Business (2018-2023) & (US$ Million)
Table 67. Glanbia Recent Development
Table 68. GSK Company Detail
Table 69. GSK Business Overview
Table 70. GSK OTC Drug and Dietary Supplement Product
Table 71. GSK Revenue in OTC Drug and Dietary Supplement Business (2018-2023) & (US$ Million)
Table 72. GSK Recent Development
Table 73. Abbott Company Detail
Table 74. Abbott Business Overview
Table 75. Abbott OTC Drug and Dietary Supplement Product
Table 76. Abbott Revenue in OTC Drug and Dietary Supplement Business (2018-2023) & (US$ Million)
Table 77. Abbott Recent Development
Table 78. Herbalife Company Detail
Table 79. Herbalife Business Overview
Table 80. Herbalife OTC Drug and Dietary Supplement Product
Table 81. Herbalife Revenue in OTC Drug and Dietary Supplement Business (2018-2023) & (US$ Million)
Table 82. Herbalife Recent Development
Table 83. Reckitt Benckiser Company Detail
Table 84. Reckitt Benckiser Business Overview
Table 85. Reckitt Benckiser OTC Drug and Dietary Supplement Product
Table 86. Reckitt Benckiser Revenue in OTC Drug and Dietary Supplement Business (2018-2023) & (US$ Million)
Table 87. Reckitt Benckiser Recent Development
Table 88. Bayer Company Detail
Table 89. Bayer Business Overview
Table 90. Bayer OTC Drug and Dietary Supplement Product
Table 91. Bayer Revenue in OTC Drug and Dietary Supplement Business (2018-2023) & (US$ Million)
Table 92. Bayer Recent Development
Table 93. Blackmores Company Detail
Table 94. Blackmores Business Overview
Table 95. Blackmores OTC Drug and Dietary Supplement Product
Table 96. Blackmores Revenue in OTC Drug and Dietary Supplement Business (2018-2023) & (US$ Million)
Table 97. Blackmores Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global OTC Drug and Dietary Supplement Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global OTC Drug and Dietary Supplement Market Share by Type: 2024 VS 2034
Figure 3. Tablets Features
Figure 4. Powders Features
Figure 5. Capsules Features
Figure 6. Liquids Features
Figure 7. Global OTC Drug and Dietary Supplement Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global OTC Drug and Dietary Supplement Market Share by Application: 2024 VS 2034
Figure 9. Convenience Stores Case Studies
Figure 10. Pharmacies Case Studies
Figure 11. Supermarkets Case Studies
Figure 12. OTC Drug and Dietary Supplement Report Years Considered
Figure 13. Global OTC Drug and Dietary Supplement Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 14. Global OTC Drug and Dietary Supplement Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 15. Global OTC Drug and Dietary Supplement Market Share by Region: 2024 VS 2034
Figure 16. Global OTC Drug and Dietary Supplement Market Share by Players in 2024
Figure 17. Global Top OTC Drug and Dietary Supplement Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Drug and Dietary Supplement as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by OTC Drug and Dietary Supplement Revenue in 2024
Figure 19. North America OTC Drug and Dietary Supplement Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 20. North America OTC Drug and Dietary Supplement Market Share by Country (2018-2034)
Figure 21. United States OTC Drug and Dietary Supplement Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 22. Canada OTC Drug and Dietary Supplement Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. Europe OTC Drug and Dietary Supplement Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. Europe OTC Drug and Dietary Supplement Market Share by Country (2018-2034)
Figure 25. Germany OTC Drug and Dietary Supplement Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. France OTC Drug and Dietary Supplement Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. U.K. OTC Drug and Dietary Supplement Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. Italy OTC Drug and Dietary Supplement Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Russia OTC Drug and Dietary Supplement Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Nordic Countries OTC Drug and Dietary Supplement Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Asia-Pacific OTC Drug and Dietary Supplement Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Asia-Pacific OTC Drug and Dietary Supplement Market Share by Region (2018-2034)
Figure 33. China OTC Drug and Dietary Supplement Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. Japan OTC Drug and Dietary Supplement Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. South Korea OTC Drug and Dietary Supplement Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. Southeast Asia OTC Drug and Dietary Supplement Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. India OTC Drug and Dietary Supplement Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. Australia OTC Drug and Dietary Supplement Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. Latin America OTC Drug and Dietary Supplement Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 40. Latin America OTC Drug and Dietary Supplement Market Share by Country (2018-2034)
Figure 41. Mexico OTC Drug and Dietary Supplement Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Brazil OTC Drug and Dietary Supplement Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Middle East & Africa OTC Drug and Dietary Supplement Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Middle East & Africa OTC Drug and Dietary Supplement Market Share by Country (2018-2034)
Figure 45. Turkey OTC Drug and Dietary Supplement Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. Saudi Arabia OTC Drug and Dietary Supplement Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 47. Pfizer Revenue Growth Rate in OTC Drug and Dietary Supplement Business (2018-2023)
Figure 48. Amway Revenue Growth Rate in OTC Drug and Dietary Supplement Business (2018-2023)
Figure 49. Suntory Revenue Growth Rate in OTC Drug and Dietary Supplement Business (2018-2023)
Figure 50. Glanbia Revenue Growth Rate in OTC Drug and Dietary Supplement Business (2018-2023)
Figure 51. GSK Revenue Growth Rate in OTC Drug and Dietary Supplement Business (2018-2023)
Figure 52. Abbott Revenue Growth Rate in OTC Drug and Dietary Supplement Business (2018-2023)
Figure 53. Herbalife Revenue Growth Rate in OTC Drug and Dietary Supplement Business (2018-2023)
Figure 54. Reckitt Benckiser Revenue Growth Rate in OTC Drug and Dietary Supplement Business (2018-2023)
Figure 55. Bayer Revenue Growth Rate in OTC Drug and Dietary Supplement Business (2018-2023)
Figure 56. Blackmores Revenue Growth Rate in OTC Drug and Dietary Supplement Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed